Literature DB >> 25771049

Metabolism of early-lactation dairy cows as affected by dietary starch and monensin supplementation.

M M McCarthy1, T Yasui1, C M Ryan1, S H Pelton1, G D Mechor2, T R Overton3.   

Abstract

The objective of this study was to evaluate the effect of dietary starch content and monensin (MON) on metabolism of dairy cows during early lactation. Before parturition, primiparous (n=21) and multiparous (n=49) Holstein cows were fed a common controlled-energy close-up diet with a daily topdress of either 0 or 400mg/d monensin. From d 1 to 21 postpartum, cows were fed a high-starch (HS; 26.2% starch, 34.3% neutral detergent fiber, 22.7% acid detergent fiber, 15.5% crude protein) or low-starch (LS; 21.5% starch, 36.9% neutral detergent fiber, 25.2% acid detergent fiber, 15.4% crude protein) total mixed ration with a daily topdress of either 0mg/d monensin (CON) or 450mg/d monensin (MON), continuing with prepartum topdress assignment. From d 22 through 63 postpartum, all cows were fed HS and continued with the assigned topdress treatment until d 63. Cows fed HS had higher plasma glucose and insulin and lower nonesterified fatty acids (NEFA) than cows fed LS during d 1 to 21 postpartum. Cows fed LS had elevated early-lactation β-hydroxybutyrate (BHBA) compared with cows fed HS. Cows fed HS had greater insulin resistance and increased plasma haptoglobin in the early lactation period. There was no effect of MON on postpartum plasma NEFA. Cows fed MON had higher plasma glucose compared with CON cows, which was driven by a MON × parity interaction in which primiparous cows fed MON had greater plasma glucose concentrations than cows fed CON. Cows fed MON had lower plasma BHBA compared with CON, which was contributed to by a MON × parity interaction in which primiparous cows fed MON had lower BHBA concentrations than CON. Starch treatment had no effect on overall liver triglyceride content. Primiparous cows fed MON had increased liver triglyceride content compared with CON primiparous cows, and multiparous cows fed MON had decreased liver triglyceride content compared with CON cows. Multiparous cows fed LS with MON had higher liver glycogen content than multiparous cows fed the LS without MON, with no effect of MON treatment for multiparous cows fed HS. There was no effect of starch or MON treatment on liver capacity to oxidize propionate to CO2, and effects of starch on gluconeogenesis were not significant. Cows fed MON tended to have greater capacity to convert propionate to glucose than CON. Supplementation with MON increased the ratio of glucose to CO2, which indicated that cows fed MON had a greater propensity to convert propionate to glucose. Overall, cows fed more propiogenic diets in early lactation (high starch or monensin) exhibited improved energy metabolism during early lactation.
Copyright © 2015 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  early lactation; metabolism; monensin; starch

Mesh:

Substances:

Year:  2015        PMID: 25771049     DOI: 10.3168/jds.2014-8821

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  3 in total

1.  Winter grazing of stockpiled native forages during heifer development delays body weight gain without influencing final pregnancy rates.

Authors:  Zachary D McFarlane; Emily R Cope; Jeremy D Hobbs; Renata N Oakes; Ky G Pohler; J Travis Mulliniks
Journal:  J Anim Sci       Date:  2018-11-21       Impact factor: 3.159

2.  Monensin supplementation downregulated the expression signature of genes involved in cholesterol synthesis in the ruminal epithelium and adipose tissue of lambs.

Authors:  H Mirzaei-Alamouti; S Moradi; A K Patra; M Mansouryar
Journal:  Trop Anim Health Prod       Date:  2022-04-20       Impact factor: 1.559

3.  Effects of a combination of plant bioactive lipid compounds and biotin compared with monensin on body condition, energy metabolism and milk performance in transition dairy cows.

Authors:  Janis Hausmann; Carolin Deiner; Amlan K Patra; Irmgard Immig; Alexander Starke; Jörg R Aschenbach
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.